Novartis Vaccines is the world's fifth-largest manufacturer and second-largest supplier of influenza vaccines in the US. The division's products include influenza, meningococcal, pediatric and travel vaccines.

 

Vaccines News  |  view more news

06 May 2008

Novartis Menveo® vaccine shows superior immune response against four types of meningitis disease in pivotal phase III trial

09 January 2008

New data show Menveo(TM) to be the first quadrivalent meningococcal vaccine to provide immunogenicity in infants

 

 

 

Features

 

 

Careers in Novartis Vaccines and Diagnostics, US
Novartis Vaccines and Diagnostics currently has US job vacancies in Vaccines, Diagnostics, Novartis Institute for Biomedical Research and Biopharmaceuticals.

 

Flu Cell Culture Technology
Cell culture-derived influenza vaccine technology (“flu cell culture”) is an innovative production process for the manufacturing of flu vaccine on the basis of cell cultures.

 

Avian Influenza
The most recent avian influenza concerns first arose in 1997, when the H5N1 avian influenza virus first moved into humans.

 

decrease text sizeincrease text size contact help

Multimedia Press Room

Visit the Novartis Vaccines & Diagnostics Multimedia Press Room for broadcast standard video, print and other multimedia files.

U.S. Healthcare Providers: Order Your FLUVIRIN® Influenza Virus Vaccine Online Today

FLUVIRIN® Influenza Virus Vaccine is now available for online ordering in the U.S. Please visit the Novartis Vaccines Direct website to place your order today.

Visit the Novartis Vaccines Direct website ›

About Novartis

About Novartis

We provide medicines to treat and prevent diseases, ease suffering and improve quality of life.

Learn more about our company

 

 

>